MRNA vs VRCA · rev $145.0M vs rev $10.9M
Moderna Inc (MRNA) versus Verrica Pharmaceuticals Inc (VRCA) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Verrica Pharmaceuticals Inc (VRCA) is a biotechnology company listed on US.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported VRCA revenue for 2026-06-30 was $10.9M. Net income was -$22.8M. VRCA currently screens at market cap $79.7M.
MRNA currently screens at market cap $24.52B. VRCA currently screens at market cap $79.7M.
Not investment advice. Open the MRNA and VRCA stock pages for the full models.
Not investment advice.